BIO-TECHNE DECLARES DIVIDEND
Bio-Techne Corporation (NASDAQ: TECH) has announced a quarterly dividend of $0.32 per share for the period ending June 30, 2022. This dividend will be payable on August 29, 2022, to all shareholders of record on August 15, 2022. The company achieved approximately $1.1 billion in net sales in fiscal 2022, and plans to consider future cash dividends quarterly. Bio-Techne provides innovative tools and reagents for research and diagnostics, aiding in drug discovery and clinical testing.
- Declaration of a quarterly dividend of $0.32 per share enhances shareholder returns.
- Company generated approximately $1.1 billion in net sales for fiscal 2022, indicating strong financial performance.
- None.
MINNEAPOLIS, Aug. 4, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately
Forward Looking Statements:
Our press releases may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act. Such statements involve risks and uncertainties that may affect the actual results of operations. Forward looking statements in this press release include statements regarding potential future repurchase of Bio-Techne common stock. The following important factors, among others, have affected and, in the future, could affect the Company's actual results and future share price: the effect of new branding and marketing initiatives, the integration of new businesses and leadership, the introduction and acceptance of new products, the funding and focus of the types of research by the Company's customers, the impact of the growing number of producers of biotechnology research products and related price competition, general economic conditions, customer site closures or supply chain issues resulting from the COVID-19 pandemic, the impact of currency exchange rate fluctuations, and the costs and results of research and product development efforts of the Company and of companies in which the Company has invested or with which it has formed strategic relationships.
For additional information concerning such factors, see the section titled "Risk Factors" in the Company's annual report on Form 10-K and quarterly reports on Form 10-Q as filed with the Securities and Exchange Commission. We undertake no obligation to update or revise any forward-looking statements we make in our press releases due to new information or future events. Investors are cautioned not to place undue emphasis on these statements.
Contact: David Clair, Vice President, Investor Relations
David.Clair@bio-techne.com
612-656-4416
View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-declares-dividend-301599814.html
SOURCE Bio-Techne Corporation
FAQ
What is the dividend amount declared by Bio-Techne (TECH) for the quarter ended June 30, 2022?
When will the dividend for Bio-Techne (TECH) be paid?
What is the record date for Bio-Techne's (TECH) dividend?
How often does Bio-Techne (TECH) declare dividends?
What were Bio-Techne's (TECH) net sales for fiscal 2022?
